Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2015

Jun 8, 2015

34975_dirs_2015-06-08_9909520e-43a8-493d-af5f-b8aa1b5d508d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-06-04

Reporting Person: HARTE NEAL J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-04 Common Stock A 14400 $0.00 Acquired 85410 Direct

Footnotes

F1: Includes (a) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; and (b) 71,010 shares of common stock held by the Reporting Person.